StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) income statement

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$676.21−13.44 (-1.95%)

Close on Nov 20, 2026Market cap $53.27BP/E 47.6Yield –

IDEXX Laboratories Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
62.4%
Operating margin
32.0%
Net margin
25.0%
Return on equity, FY2025
66.2%

Financial strength

Current ratio
1.17
Debt to equity
0.28
Debt to assets
13.1%
Cash to current liabilities
15.3%

Valuation

P/E ratio
47.6
Price to sales
11.70
Price to book
33.04
Dividend yield
–

See a number that looks wrong?